Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pidilizumab (CT-011), a humanized IgG1κ anti-PD-1 monoclonal antibody, serves as a DLL1 antagonist with potential applications in researching hematologic malignancies [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Pidilizumab (CT-011), a humanized IgG1κ anti-PD-1 monoclonal antibody, serves as a DLL1 antagonist with potential applications in researching hematologic malignancies [1]. |
Synonyms | CT-011, MDV9300 |
Molecular Weight | N/A |
CAS No. | 1036730-42-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pidilizumab 1036730-42-3 Apoptosis Cell Cycle/Checkpoint Immunology/Inflammation PD-1/PD-L1 CT-011 MDV9300 inhibitor inhibit